Literature DB >> 1662964

Inhibition of adenylate-cyclase-coupled G protein complex by ototoxic diuretics and cis-platinum in the inner ear of the guinea pig.

T Koch1, B Gloddek.   

Abstract

The enzyme adenylate cyclase produces the second messenger cAMP and is located in the mammalian inner ear, predominantly in the stria vascularis and to a lesser extent in the organ of Corti. It is coupled to hormone receptors and regulating G proteins in the outer cell membrane. By means of immunofluorescence in cryostat sections of the guinea pig cochlea, we could demonstrate the G proteins Gs and Gi, which belong to the adenylate cyclase complex. These proteins had their highest density in the stria vascularis. In membrane preparations of this tissue, the adenylate cyclase complex was inhibited by ototoxic drugs (furosemide, ethacrynic acid and cis-platinum). Stimulation at different sites of the enzyme system showed that the target of these drugs was probably the regulating G protein complex and not the enzyme molecule itself. Inhibition depended on the concentration of the drug and the incubation time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662964     DOI: 10.1007/bf00627634

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  33 in total

1.  Actions of "loop" diuretics and mercurials upon the cochlea.

Authors:  R Thalmann; I Ise; B A Bohne; I Thalmann
Journal:  Acta Otolaryngol       Date:  1977 Jan-Feb       Impact factor: 1.494

2.  Adenylate cyclase and cochlear fluid balance.

Authors:  J Schacht
Journal:  Am J Otolaryngol       Date:  1982 Sep-Oct       Impact factor: 1.808

3.  Ultrastructural and electrophysiological studies of acute ototoxic effects of furosemide.

Authors:  A Forge; A M Brown
Journal:  Br J Audiol       Date:  1982-05

4.  Effect of ethacrynic acid, furosemide, and ouabain upon the endolymphatic potential and upon high energy phosphates of the stria vascularis.

Authors:  J Kusakari; I Ise; T H Comegys; I Thalmann; R Thalmann
Journal:  Laryngoscope       Date:  1978-01       Impact factor: 3.325

5.  Permanent deafness associated with furosemide administration.

Authors:  C A Quick; W Hoppe
Journal:  Ann Otol Rhinol Laryngol       Date:  1975 Jan-Feb       Impact factor: 1.547

6.  Sensorineural hearing loss owing to deficient G proteins in patients with pseudohypoparathyroidism: results of a multicentre study.

Authors:  T Koch; E Lehnhardt; H Böttinger; T Pfeuffer; D Palm; B Fischer; H Radeke; R D Hesch
Journal:  Eur J Clin Invest       Date:  1990-08       Impact factor: 4.686

7.  Propranolol antagonism to the effect of furosemide on the compostion of endolymph in guinea pigs.

Authors:  S W Brusilow
Journal:  Can J Physiol Pharmacol       Date:  1976-02       Impact factor: 2.273

8.  Vasopressin and isoproterenol activate adenylate cyclase in the guinea pig inner ear.

Authors:  H P Zenner; B Zenner
Journal:  Arch Otorhinolaryngol       Date:  1979

9.  Characteristics and drug responses of cochlear and vestibular adenylate cyclase.

Authors:  D Bagger-Sjöbäck; C S Filipek; J Schacht
Journal:  Arch Otorhinolaryngol       Date:  1980

10.  [Cisplatin ototoxicity. A clinical study].

Authors:  M Schröder; R Laskawi; E Stennert; H Kühnle; F W Thiele
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1986-02
View more
  4 in total

Review 1.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  Immunohistochemical localization of α2-adrenergic receptors in the neonatal rat cochlea and the vestibular labyrinth.

Authors:  Jing Cai; Jianfeng Li; Yanyan Mao; Xiaohui Bai; Lei Xu; Haibo Wang
Journal:  J Mol Neurosci       Date:  2013-08-22       Impact factor: 3.444

3.  Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer.

Authors:  Süleyman Yilmaz; Fatih Oktem; Emin Karaman
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-28       Impact factor: 2.503

4.  Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome.

Authors:  Abhijeet Saha; Vivek Gupta; Kanika Kapoor; N K Dubey; Priti Lal; T S Sidhu; V V Batra; A D Upadhyay
Journal:  Pediatr Nephrol       Date:  2012-12-12       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.